KDR and neoplasm: 75-77 Conceivably, tumor angiogenesis presents a uniquely attractive target therapy in all types of human tumors, and by interfering with the intracellular signaling of VEGF and VEGFR, anti-angiogenic therapy inhibits the growth of tumor vessels. 50,78-80